Erez Chimovits

Director; Director, 10% Owner · 4 filings · Latest: Sep 28, 2026

ADARx Pharmaceuticals, Inc.

Braveheart Bio, Inc.

Upstream Bio, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ADRX	Erez Chimovits	Director	Sep 28, 2026	Purchase	$17.00	61,516	$1.0M	9,292,025	Sep 30 9:29 PM
BRVE	Erez Chimovits	Director, 10% Owner	Aug 7, 2026	Purchase	$18.00	1,940,000	$34.9M	273,333	Aug 11 9:31 PM